Latest Supply Agreements News

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Metallium Limited has secured exclusive lease options for two fully permitted U.S. sites, advancing its strategy to deploy its Flash Joule Heating technology across multiple states. This move complements its flagship Texas campus and positions the company for rapid scale-up in the growing e-waste metal recovery sector.

Amaero Ltd reported a 470% revenue surge to $3.8 million for FY2025, driven by expanded production capacity and exclusive supply deals, while continuing to invest heavily in infrastructure and operations, resulting in a $24.4 million loss.

The a2 Milk Company delivered record FY25 results with $1.9 billion in sales and announced a transformative acquisition of a New Zealand manufacturing facility, alongside divesting its stake in Mataura Valley Milk and planning a $300 million special dividend.

Contact Energy Limited reported a robust FY25 with a 13% increase in underlying net profit, driven by geothermal expansion and strategic acquisition of Manawa Energy. The company’s renewable portfolio and risk management positioned it well amid challenging market conditions.

Atomo Diagnostics has successfully placed $416,611.77 from its Share Purchase Plan shortfall, bolstered by a recent US order from Lumos Diagnostics. This capital injection strengthens Atomo’s position as it scales up production of its Pascal cassettes.

Etherstack’s US subsidiary has locked in a significant seven-year Master Supply Agreement with AT&T, promising steady revenue and validating its mission-critical telecom technology.

RooLife Group Ltd has successfully raised $2 million through an oversubscribed strategic placement, positioning the company to expand its e-commerce footprint across key international markets.

RooLife Group has secured a two-year supply agreement with Eternal Asia, granting access to over one million retail outlets across China and potential annual orders worth up to AUD 110 million.

PARKD Limited has marked a strong finish to FY25 with the launch of innovative modular construction products and a national supply agreement, positioning itself for growth across Australia’s expanding infrastructure sectors.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.